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Abstract Oxidative modification of glucose-6-phosphate dehy-
drogenase (Glu-6-PDH), as observed for other proteins, 
increases the susceptibility of the protein to degradation by the 
multicatalytic proteinase/proteasome (MCP). Oxidized Glu-6-
PDH is, however, more prone to cross-linking reactions by the 
lipid peroxidation product 4-hydroxy-2-nonenal (HNE), proc-
esses which render the protein resistant to proteolysis. In 
addition, HNE cross-linked protein inhibits the degradation of 
oxidatively modified glutamine synthetase by the MCP. In 
contrast to oxidized Glu-6-PDH, which inhibits the proteolysis of 
GS in a competitive manner, HNE cross-linked protein acts as a 
noncompetitive inhibitor. As judged by binding of the hydro-
phobic fluorescent probe 8-anilino-l-naphthalenesulfonic acid, a 
common structural feature of both macromolecular substrates 
and inhibitors of the M C P is an increased accessibility of 
hydrophobic regions on the protein. 
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1. Introduction 
Protein can be oxidatively modified by a variety of cellular 
oxidation systems (for review see [1]). These forms of protein 
are generally degraded more rapidly than their native counter-
parts [2-A]. The steady-state level of oxidized protein therefore 
reflects the balance between the rates of protein oxidation and 
the rates of degradation of oxidized protein. In certain tissues, 
the level of oxidized protein increases with age and in re-
sponse to oxidative stress, while age-related decreases in alka-
line protease activity have been reported [5-7]. It has therefore 
been theorized that the age-related increase in the levels of 
oxidized protein is, at least in part, a result of a decline in 
its ability to be degraded [8]. 
A major cytosolic alkaline protease, the multicatalytic pro-
teinase/proteasome (MCP), has been implicated in the degra-
dation of various oxidatively modified forms of protein [9-11]. 
The activity of the M C P may decline due to a decrease in the 
amount or specific activity of the enzyme and/or to an in-
crease in the level of endogenous inhibitors of the proteinase. 
We have recently shown that the model protein glucose-6-
phosphate dehydrogenase (Glu-6-PDH) from the bacterium 
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Leuconostoc mesenteroides, modified by the lipid peroxidation 
product 4-hydroxy-2-nonenal (HNE), was not degraded by 
the M C P and inhibited the ability of this proteinase to de-
grade oxidized forms of protein [12]. The inhibitory effect was 
associated with the formation of cross-linked Glu-6-PDH, 
which exhibited fluorescence reminiscent of that observed 
for lipofuscin (for review see [13]). Cross-linking occurs 
upon reaction of lysine residues with bifunctional H N E [14]. 
These observations therefore suggest that age- and disease-
related increases in oxidized protein, lipofuscin, and/or ceroid 
pigments may be due, at least in part, to modification of 
protein by lipid peroxidation products [15-18]. Because of 
the potentially important implications of modification of pro-
tein by H N E , we have investigated the ability of oxidized 
forms of protein to be cross-linked by H N E and the mecha-
nism^) by which HNE-modified protein inhibits the M C P . 
2. Materials and methods 
2.1. 4-Hydroxy-2-nonenal preparation 
HNE was prepared by acid treatment of 4-hydroxy-2-nonenal di-
methylacetal which was synthesized as described by De Montarby et 
al. [19] and purified as previously reported [14]. The HNE concentra-
tion was determined by measurement of UV absorbance at 224 nm 
(e= 13 750 IVT1 cm"1). 
2.2. Glucose-6-phosphate dehydrogenase preparation and modification 
Glu-6-PDH from Leuconostoc mesenteroides was purchased from 
Worthington Biochemical Corporation. The lyophilized enzyme pow-
der was dissolved in 25 mM KH 2P0 4 , 100 mM KCl, pH 7.4 and 
dialyzed overnight at 4°C against the same buffer using Spectra Por 
dialyzing membrane (MW cut-off 10000). Oxidative modification of 
the enzyme was achieved by incubating Glu-6-PDH (20 uM) with 
FeS04 (1 mM) and citrate (1.2 mM) in 5 mM KH 2P0 4 , pH 7.0, 
for 2 min at room temperature under aerobic conditions. The reaction 
was terminated by addition of 100 mM citrate, pH 7.4. Residual 
activity of the modified enzyme was determined using a spectropho-
tometric assay as previously described [20]. HNE treatment of native 
and oxidized Glu-6-PDH (2.5 mg/ml) was performed in 25 mM 
KH 2P0 4 , 100 mM KCl, pH 7.4 with 0 ^ mM HNE. At indicated 
times (0-A h), the reaction was quenched with 10 mM NaBH4 for 15 
min at 25°C and the sample was passed over a PD-10 column (Phar-
macia LKB Biotechnology Inc.) equilibrated with 50 mM HEPES, 
100 mM KCl, pH 7.8. Intermolecular cross-linking of Glu-6-PDH 
by HNE was monitored by gel filtration chromatography on a Zorbax 
GF 250 column equilibrated with 1% SDS in 100 mM NaH2P04 , pH 
7, at a flow rate of 2 ml/min using a Hewlett-Packard 1090 liquid 
Chromatograph. The enzyme was diluted to a concentration of 4 uM 
in elution buffer prior to analysis of a 250 ul aliquot of the diluted 
solution. 
2.3. 8-Anilino-1-naphthalene sulfonic acid binding 
The various forms of Glu-6-PDH at a concentration of 0.4 uM 
were incubated with 100 uM 8-anilino-1-naphthalenesulfonic acid 
(ANSA) (Sigma Chem. Co.) at 37°C in 50 mM HEPES, 100 mM 
KCl, pH 7.8. The fluorescence emission spectra (excitation, 370 nm) 
were obtained using a Photon Technology International LS 100 spec-
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trofluorimeter. Binding of ANSA to protein was observed after sub-
traction of the emission spectrum of ANSA from that of ANSA in the 
presence of enzyme. 
2.4. Proteolytic assays 
The MCP was purified from rat liver acetone powder (Sigma Chem. 
Co.) following the procedure of Skilton et al. [21] with minor mod-
ifications as previously described [22]. Proteolysis of various forms of 
Glu-6-PDH by the MCP was performed at 37°C in 50 mM HEPES, 
100 mM KCl at pH 7.8 as previously described [22]. Following TCA 
precipitation of the protein, the rate of proteolysis was determined by 
monitoring increases in the concentration of small peptides in the 
supernatant. Upon reaction of peptide amino groups with fluoresc-
amine (Sigma), the formation of fluorescent derivatives was monitored 
by measuring emission intensities at 475 nm (excitation, 375 nm). A 
calibration curve was obtained in parallel using glycine as the stand-
ard. 
Proteolysis of GS was measured by incubating the MCP (0.3 |xM) 
at 37°C with oxidized radio-labeled GS (8 uM) in 50 mM HEPES, 
100 mM KCl, 0.4 mM MgCl2, pH 7.8 in the absence or presence of 
native or HNE modified Glu-6-PDH. At appropriate times, 10 ul 
aliquots were removed and diluted with 12.5% TCA to a final volume 
of 50 ul. After centrifugation of the precipitated proteins for 10 min at 
14000 rpm in an Eppendorf microfuge, the concentration of small 
peptides present in the supernatant was determined by measuring 
the radioactivity of each sample using a Tricarb 2200 CA liquid scin-
tillation analyzer. 14C-labeled GS was purified from the over-produc-
ing strain E. coli K12 pglnó YMC10 grown in a synthetic medium 
supplemented with 14C-amino acids (Dupont NEN and ICN) as pre-
viously described [23]. The specific radioactivity obtained was 
4000 ± 300 cpm/ug of GS. Radio-labeled enzyme was oxidized by ex-
posure to 0.1 mM FeCl3 and 25 mM ascorbate for 8 h at 37°C [23]. 
3. Results 
3.1. Cross-linking of native and oxidized glucose-6-phosphate 
dehydrogenase by 4-hydroxy-2-nonenal 
The appearance of intermolecular cross-links during incu-
bation of native and oxidized Glu-6-PDH with HNE was 
monitored by SDS gel filtration chromatography as previ-
ously described [12]. Prior to analysis, samples were reduced 
with sodium borohydride to quench the reaction and stabilize 
the cross-link. In the presence of 1.0% SDS, native dimeric 
enzyme dissociated and eluted in the monomeric form. As 
shown in Fig. 1A,B, treatment of both native and oxidized 
forms of Glu-6-PDH with HNE resulted in a time- and con-
centration-dependent increase in multimeric protein. Oxidized 
enzyme was more susceptible to cross-linking. Cross-linking 
resulted in the formation of primarily dimeric and tetrameric 
protein with no appearance of large aggregates or protein 
precipitates under the conditions used in these experiments. 
3.2. Decrease in proteolytic susceptibility of oxidized 
Glu-6-PDH after treatment with HNE and inhibition of 
the multicatalytic proteinase 
In the remainder of this report, the phrase 'HNE-treated 
Glu-6-PDH' refers to oxidatively modified Glu-6-PDH that 
was exposed to 4.0 mM HNE for 4 h. The rates of proteolysis 
for native, oxidized, and HNE-treated forms of the protein 
were determined by monitoring the increase in small peptide 
concentration after incubation with the MCP. As shown in 
Fig. 2, oxidation of native Glu-6-PDH by iron and citrate led 
to increased susceptibility of the protein to proteolysis by the 
MCP. It is interesting to note that enzyme modified in this 
manner lost 50% of its initial activity associated with oxida-
tion of one active site lysine residue [20]. Treatment of oxi-
dized Glu-6-PDH with HNE rendered the protein resistant to 
proteolysis (Fig. 2). In addition, this form of the enzyme pre-
vented the degradation of oxidatively modified 14C-labeled GS 
(Fig. 3), as has been reported for native Glu-6-PDH cross-
linked by HNE [12]. Not surprisingly, oxidized Glu-6-PDH 
and to a lesser extent native enzyme also interfered with the 
degradation of oxidized GS likely due to substrate competi-
tion. 
3.3. Noncompetitive inhibition of the MCP by HNE 
cross-linked Glu-6-PDH 
To further investigate the mechanism of MCP inhibition, 
the rate of proteolysis of oxidized GS was determined at dif-
ferent substrate and inhibitor concentrations. As shown in 
Fig. 4A, oxidized Glu-6-PDH inhibited the proteolysis of oxi-
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Fig. 1. Intermolecular cross-linking of native and oxidized Glu-6-PDH by HNE. Native and oxidized Glu-6-PDH (2.5 mg/ml) were incubated 
at 37°C in 25 mM KH2P04, 100 mM KCl at pH 7.4 with 4 mM HNE for 0, 0.5, 1.0, 2.0, and 4.0 h or with 0, 1, 2, 3, and 4 mM HNE for 
4 h. At indicated times, the sample was treated with 10 mM NaBH4 for 15 min at 25°C. Protein was then diluted to 0.2 mg/ml in elution buf-
fer followed by gel filtration chromatography of a 250 ul aliquot. Protein elution was monitored at 280 nm with 1.0% SDS in 100 mM 
NaH2P04, at pH 7.0, as eluant at a flow rate of 2 ml/min. The peak area of the multimeric cross-linked protein (expressed as % of total, i.e. 
monomeric+multimeric peak areas) is plotted as a function of time (A) or HNE concentration (B) for native (D) and oxidized (o) Glu-6-PDH. 
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dized GS by the MCP in a competitive manner (Fig. 4A) as 
expected for substrate competition. In contrast, proteolysis of 
oxidized GS was inhibited by HNE cross-linked Glu-6-PDH 
in a noncompetitive manner (Fig. 4B). When native Glu-6-
PDH is cross-linked by HNE it also acts as a noncompetitive 
inhibitor (data not shown). The observation that inhibition of 
the proteinase is noncompetitive invites speculation that the 
MCP reacts with HNE released from Glu-6-PDH and/or with 
free functional groups of the protein-HNE derivative. This 
does not appear to be the case since treatment of HNE-modi-
fied Glu-6-PDH with NaBH4, which reduces remaining func-
tional groups and stabilizes protein adducts to dissociation, 
does not alter the ability of HNE cross-linked protein to in-
hibit the MCP. 
3.4. ANSA binding to HNE-treated forms of Glu-6-PDH 
Binding of the hydrophobic probe ANSA to protein is a 
useful tool for assessing the accessibility of hydrophobic re-
gions of protein to solvent [24]. When bound to protein, 
ANSA exhibits an increase in fluorescence. As previously re-
ported [22], in contrast to native enzyme, oxidized Glu-6-PDH 
binds ANSA (Fig. 5). When native or oxidized Glu-6-PDH is 
exposed to HNE for extended periods of time, the protein 
becomes cross-linked and binds ANSA (Fig. 5). In addition, 
ANSA binds to the MCP and to oxidized GS and inhibits the 
MCP (results not shown). Since oxidized and HNE cross-
linked forms of Glu-6-PDH act as macromolecular substrate 
or inhibitors of the MCP, respectively, an increase in the 
accessibility of hydrophobic regions may reflect a common 
feature of macromolecular ligand recognition by the protein-
ase. It should be noted that Glu-6-PDH can be inactivated 
by HNE under relatively mild reaction conditions. Under 
these conditions, the protein does not become cross-linked, 
does not bind the hydrophobic probe ANSA, and exhibits 
20-
[Glu-6-PDH]/iM 
Fig. 2. Proteolysis of native, oxidized, and HNE-treated oxidized 
Glu-6-PDH by the MCP. Proteolysis of native and modified forms 
of Glu-6-PDH by the MCP (0.3 uM) was performed and monitored 
as described in Section 2. The rates of proteolysis for native (D), 
oxidized (o), and HNE-treated oxidized Glu-6-PDH ( A ) are pre-
sented as a function of protein concentration. Points represent the 
mean, and bars the standard deviation of the mean for three inde-
pendent experiments. 
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Fig. 3. Proteolysis of oxidized GS by the MCP in the presence of 
various forms of Glu-6-PDH. Proteolysis of radio-labeled oxidized 
GS (8 |iM) by the MCP (0.3 uM) was determined in the presence 
of native and modified forms of Glu-6-PDH as described in Section 
2. The rates of GS proteolysis are presented as a function of native 
(D), oxidized (o), and HNE-treated oxidized Glu-6-PDH ( A ) . 
Points represent the mean, and bars the standard deviation of the 
mean for three independent experiments. 
no change in proteolytic susceptibility [22]. These results sup-
port the conclusion that increased accessibility of hydrophobic 
regions on protein is a structural feature required for both 
substrate and inhibitor recognition by the protease. 
4. Discussion 
Modification of protein by lipid peroxidation products such 
as malondialdehyde and HNE has been implicated in various 
degenerative diseases associated with aging [25-28]. The 
present study was undertaken to determine if the fate of al-
tered forms of protein obtained by reaction with HNE would 
be similar to that of oxidized protein. Oxidative modification 
of Glu-6-PDH, as reported for other enzymes, renders the 
protein more susceptible to degradation by the MCP [2^1]. 
Subsequent treatment of oxidatively modified Glu-6-PDH 
with HNE led to the formation of cross-linked protein which 
was resistant to proteolysis and served as an inhibitor of the 
MCP. In addition, oxidized Glu-6-PDH is more prone to 
cross-linking than the native enzyme, suggesting a potentially 
important mechanism by which oxidatively modified protein 
may accumulate with age and in various pathological condi-
tions. The occurrence of such modified forms of protein may 
contribute to a reduced ability of the MCP to efficiently de-
grade damaged protein in vivo. As a noncompetitive inhibitor, 
HNE cross-linked protein would be a good candidate for 
promoting the accumulation of damaged protein since non-
competitive inhibitors are not sensitive to substrate concen-
tration. It may be argued that the concentration of HNE used 
to cross-link Glu-6-PDH in these experiments is nonphysio-
logical. This protein was used as a model to study interaction 
of HNE with amine residues on protein. It appears that sim-
ilar cross-linking chemistry occurs in cellular organelles at low 
concentrations of HNE [14]. Arginase, a tetrameric protein, 
and carbonic anhydrase, a monomer, purified from bovine 
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Fig. 4. Double reciprocal plot of the rate of GS proteolysis versus GS concentration in the absence and presence of oxidized or HNE-treated 
Glu-6-PDH. Proteolysis of radio-labeled oxidized GS (4, 6, 8 and 12 uM) by the MCP (0.3 uM) was monitored as described in Section 2 in 
the absence (o) and presence of 16 uM ( A ) and 32 uM (D) oxidized Glu-6-PDH (A) or HNE-treated oxidized Glu-6-PDH (B). 
liver and erythrocytes, respectively, also become cross-linked 
upon exposure to HNE and resistant to proteolysis by the 
MCP (unpublished). 
In an effort to determine the molecular mechanism whereby 
protein cross-linked by HNE inhibits the MCP, binding stud-
ies with the hydrophobic probe ANSA were performed. Un-
like native enzyme, oxidized and HNE cross-linked forms of 
Glu-6-PDH bound ANSA efficiently, suggesting that a com-
mon structural feature of both macromolecular substrates and 
inhibitors of the MCP is an increased accessibility of hydro-
phobic regions on the protein. Indeed, exposure of hydropho-
bic regions in protein upon oxidative modification has been 
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Fig. 5. Spectrofluorimetric analysis of ANSA binding to the various 
forms of Glu-6-PDH. Emission spectra (excitation 370 nm) of 
ANSA (100 uM) in the presence of the various forms of Glu-6-
PDH (0.4 uM) were performed as described in Section 2. The in-
crease in fluorescence intensity (Kn^ = 490 nm) resulting from the 
binding of ANSA to the enzyme was determined by subtracting the 
emission spectrum of ANSA from that of ANSA in the presence of 
the different forms of the enzyme: native ( ), oxidized ( ), 
HNE-treated ( ), and HNE-treated oxidized (••••) Glu-6-
PDH. 
proposed to be a key event for substrate recognition by the 
MCP [4,22,29]. The noncompetitive inhibition observed with 
HNE cross-linked Glu-6-PDH could therefore be explained 
by a very slow off rate of the cross-linked Glu-6-PDH from 
a common hydrophobic site of recognition. This hypothesis is 
supported by the observation that ANSA binds to the MCP 
and inhibits the proteolysis of oxidized protein by the MCP. 
In addition, the MCP only releases short proteolytic peptide 
fragments [22,30,31]. Thus, the protein inhibitor may be re-
tained at a hydrophobic recognition site of the MCP by virtue 
of its cross-linked structure. 
These findings suggest a plausible mechanism for the ob-
served accumulation of damaged protein during the progres-
sion of certain degenerative diseases associated with increased 
rates of free radical production. Oxidized protein is more 
prone to HNE cross-linking reactions leading to the forma-
tion of material which is not efficiently degraded and inhibits 
the MCP. Both effects appear to result from increases in the 
accessibility of hydrophobic regions on the protein. The fact 
that inhibition is noncompetitive underscores the potential for 
a buildup of damaged protein upon oxidative stress. 
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